WTT yields 47.10% · JNJ yields 2.13%● Live data
📍 WTT pulled ahead of the other in Year 1
Combined, WTT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WTT + JNJ for your $10,000?
Wireless Telecom Group, Inc., together with its subsidiaries, designs, develops, manufactures, and markets radio frequency (RF) and microwave devices in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company also engages in development, testing, and deployment of wireless technology. In addition, it offers power meters and sensors, voltmeters, and audio and modulation analyzers for radar, avionics, electronic warfare, electromagnetic interference compatibility, and satellite and wireless communications applications; and noise generation instruments, calibrated noise sources, noise modules, and diodes. Further, the company provides phase noise analyzers and signal generators; embedded signal processing and radio frequency modules; and long-term evolution physical layer and stack software for mobile network and related applications. It serves wireless carriers, aerospace and defense companies, military and government agencies, satellite communication companies, network equipment manufacturers, semiconductor companies, system integrators, tower companies, neutral host providers, medical device manufacturers, and other technology companies. The company markets its products under the Boonton, Noisecom, Holzworth, and CommAgility brands through its in-house sales force, manufacturers' representatives, and distributors. Wireless Telecom Group, Inc. was incorporated in 1985 and is headquartered in Parsippany, New Jersey.
Full WTT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.